Task: Answer the multiple-choice question.
Query: Which compound exhibits a -20.351% hERG inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a: Cc1cc(C(=O)COC(=O)C2=NNC(=O)CC2)c(C)n1CCc1ccccc1
b: CCOc1ccc(NC(=O)CSc2nc3cccnc3n2CCOC)cc1
Answer: b. CCOc1ccc(NC(=O)CSc2nc3cccnc3n2CCOC)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCOc1ccc(NC(=O)CSc2nc3cccnc3n2CCOC)cc1
CCOc1ccc(NC(=O)CSc2nc3cccnc3n2CCOC)cc1
N-(4-ethoxyphenyl)-2-[3-(2-methoxyethyl)imidazo[4,5-b]pyridin-2-yl]sulfanylacetamide